Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results Expects continued strong financial and operating momentum in 2021, forecasting total revenues of $2 billion at the midpoint and Adjusted EBITDA of $780 million at the midpoint, both increases...

Emergent BioSolutions Announces Preliminary 2019 Financial Results and Provides 2020 Financial Forecast Full year 2019 preliminary revenues and adjusted profitability metrics in line with prior guidanceFull year 2020 forecast reflects continued growth of core business as well as investments in key...

Emergent BioSolutions Announces Preliminary 2018 Financial Results and Provides 2019 Financial Forecast Full year 2018 preliminary performance in line with recently revised guidanceFull year 2019 forecast reflects continued growth of organic business and anticipated positive impact of recent...